Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ZX008 Expanded Access Protocol - Dravet Syndrome Treatment Plan

NCT03780127 is registered in ClinicalTrials.gov with Zogenix, Inc. as lead sponsor.

NCT NCT03780127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03780127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ZX008 Expanded Access Protocol - Dravet Syndrome Treatment Plan
Lead sponsor
Zogenix, Inc.
Phase
Expanded access
Overall status
Approved for marketing
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dravet syndrome